Impact of morning symptoms in clinical control of Chronic Obstructive Pulmonary Disease (COPD) - IMPAEPOC

Inclusion Criteria

• Inclusion Criteria:
• - Patient has signed informed consent form
• - Patients of both sexes,> 40 years.
• - Patients diagnosed with COPD according to global consensus on the definition, classification and management of the disease (GOLD) criteria:
• * post-bronchodilator forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) <70%
• * post-bronchodilator FEV1 <80% (stage II, III and IV)
• Exclusion Criteria:
• - Participating in an epidemiological study or clinical trial
• - Patient with other respiratory disease than COPD (eg bronchial asthma, cystic fibrosis, severe bronchiectasis, restrictive lung disease, cancer, etc.).
• - Patients with mild COPD: FEV1> 80%